Endothelial dysfunction in heart failure.

Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 1

Abstract

Endothelial dysfunction crucially contributes to the development of impaired coronary and systemic perfusion as well as reduced exercise capacity in patients with congestive heart failure, with fundamental impact on morbidity and mortality. Reduced bioavailability of nitric oxide (NO) and abundant formation of reactive oxygen species (ROS) within the vascular wall are the key determinants in endothelial dysfunction. The disbalance between NO and ROS mainly results from neurohumoral activation associated with heart failure. As endothelial derived NO is a major endogenous modulator of platelet function, reduced intravascular bioactivity of NO contributes to platelet activation, adhesion and thromboembolic events in heart failure. Treatment with angiotensin converting enzyme (ACE) inhibitors, angiotensin and aldosterone antagonists, and statins beneficially modulates endothelial dysfunction in heart failure. All these therapies increase NO bioactivity by either modulation of ROS generation, thereby preventing the interaction of superoxide anions with NO, and/or increasing endothelial NO synthase (eNOS) expression/activity. AVE9488, a novel eNOS transcription enhancer, attenuates cardiac remodeling and endothelial dysfunction in rats after large myocardial infarction. Endothelial progenitor cell (EPC) levels and their mobilization are regulated by eNOS. After myocardial infarction in rats, EPC levels and formation of endothelial colony forming units are markedly reduced. AVE 9488, ACE or HMG-CoA reductase inhibition result in significant increases in EPC levels, and beneficial effects on bone marrow molecular alterations after myocardial infarction.

Authors and Affiliations

Johann Bauersachs, Julian D Widder

Keywords

Related Articles

Experimental asthma in rats.

Animal models of asthma have been used for over 100 years. The accuracy of extrapolations from animal models to human asthmatics is highly dependent on the species of animal selected. The rat, in comparison with other an...

Mechanism of action of clozapine in the context of dopamine D(1)-D(2) receptor hetero-dimerization - a working hypothesis.

The tight correlation between the clinical potency and the D(2)R blocking action of antipsychotic medications suggests that dopamine hyperactivity plays a significant role in psychosis. Clozapine, one of the most effecti...

Prediction of enzyme activity with neural network models based on electronic and geometrical features of substrates.

Background: Artificial Neural Networks (ANNs) are introduced as robust and versatile tools in quantitative structure-activity relationship (QSAR) modeling. Their application to the modeling of enzyme reactivity is discus...

Different effects of nitric oxide synthase inhibitors on convulsions induced by nicotine in mice.

Acute intraperitoneal (ip) administration of N(G)-nitro-L-arginine (NNA, 10, 20 and 40 mg/kg), a non-selective nitric oxide synthase (NOS) inhibitor, significantly and dose-dependently decreased the incidence of convulsi...

Cyclic AMP generating system in human microvascular endothelium is highly responsive to adrenaline.

We have tested cultured human microvascular endothelial cells (HMEC-1) for their ability to synthesize cyclic adenosine 3',5'-monophosphate (cAMP) in the absence or presence of various drugs. The accumulation of cAMPwas...

Download PDF file
  • EP ID EP91326
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Johann Bauersachs, Julian D Widder (2008). Endothelial dysfunction in heart failure.. Pharmacological Reports, 60(1), 119-126. https://europub.co.uk/articles/-A-91326